Muscle & Nerve · 2002 · 148 citations · 21 references
Life SciencesPharmacologyPhysiologyMolecular PharmacologyPathophysiologySignal TransductionMuscle PathologyMuscle PhysiologyNeuromuscular PhysiologyReceptor PharmacologyReceptor PhysiologyAdrenergic Receptor AgonistsCellular HypertrophyDenervation-induced AtrophyMuscle Atrophy MechanismsMuscle Fiber HypertrophyMuscle HypertrophyMuscle Hypertrophy MechanismsSkeletal Muscle Physiology
Analyses were performed to evaluate the roles of the beta1- and beta2-adrenergic receptors in the skeletal muscle hypertrophy and anti-atrophy response to the beta-adrenergic agonist, clenbuterol. Treatment of wild-type mice with clenbuterol resulted in statistically significant hypertrophy of the innervated tibialis anterior and medial gastrocnemius muscles and inhibition of denervation-induced atrophy of these muscles. Treatment of beta1-adrenergic receptor knockout mice with clenbuterol also resulted in statistically significant hypertrophy of the innervated tibialis anterior and medial gastrocnemius muscles and inhibition of denervation-induced atrophy of these muscles. In contrast, in beta2-adrenergic receptor knockout mice and in mice lacking both the beta1- and beta2-adrenergic receptors, clenbuterol treatment did not result in hypertrophy of the innervated tibialis anterior and medial gastrocnemius muscles, nor did it inhibit denervation-induced atrophy in these muscles. Together these data demonstrate that the beta2-adrenergic receptor is responsible for both the skeletal muscle hypertrophy and anti-atrophy effects of the beta-adrenergic agonist clenbuterol.
21
Targeted Disruption of the β2 Adrenergic Receptor Gene
Andrzej Chruscinski, Daniel Rohrer, Eric Schauble et al. · Journal of Biological Chemistry · 1999 · 333 citations · Full text
Medicine, Cardiology, Pharmacology +11
Cimaterol-Induced Muscle Hypertrophy and Altered Endocrine Status in Lambs
D. H. Beermann, W.R. Butler, D. E. Hogue et al. · Journal of Animal Science · 1987 · 176 citations